Internal Medicine Alert – August 15, 2012
August 15, 2012
View Issues
-
Might That Medrol Dosepak Trigger a Suicide?
Adults treated with glucocorticoids in a primary care setting have a five-fold increase in suicide or suicidal behavior and other severe neuropsychiatric disorders. The risk is highest with first-time use of these medications. -
Does Aortic Valve Calcification Predict Cardiovascular Events?
The presence of aortic valve calcification (AVC) predicts cardiovascular and coronary event risk independent of traditional risk factors and inflammatory biomarkers, likely due to the strong correlation between AVC and subclinical atherosclerosis. -
Studying the Issue of Off-label Prescribing in Primary Care
Off-label prescribing is common in primary care and most of the time lacks the scientific evidence to support it. -
Phentermine/Topiramate Extended-Release Capsules (Qsymia CIV)
THE FDA HAS APPROVED A SECOND WEIGHT-LOSS DRUG WITHIN the last month. This product is a combination of phentermine, an anorectic, and the antiepileptic topiramate. Phentermine/topiramate (PHEN/TPM) is manufactured by Catalent Pharma Solutions and marketed by Vivus Inc. as Qsymia. -
Clinical Briefs
Clinical Briefs: Risk for Zoster from the Vaccine in Immunosuppressed Persons, Elucidating the Best, Cerebral Aneurysms: Whats in Your Patients Future? -
CME Objectives/CME Instructions/CME Questions
CME Objectives/CME Questions -
ECG Review
The ECG was obtained from a patient whose blood pressure was dropping. How many reasons can you cite to support a diagnosis of ventricular tachycardia (VT)?